Jean-Marc Pardonge appointed as new President of Aptar Pharma Prescription Division
Posted: 19 November 2012 | European Pharmaceutical Review | No comments yet
Jean-Marc Pardonge, 52 years old, has been appointed as the new President of Aptar Pharma’s Prescription Division, world leader in the development and manufacturing of nasal and pulmonary drug delivery devices.
Jean-Marc Pardonge, President, Aptar Pharma Prescription Division
Jean-Marc Pardonge succeeds Salim Haffar, and becomes the new General Manager of Aptar Stelmi (the Stelmi company was recently acquired by Aptargroup).
After graduating from the French ENSAM engineering school (Ecole Nationale Supérieure d’Arts et Métiers), Jean-Marc Pardonge joined Aptar Pharma Prescription Division in 2000 as R&D Manager. He was promoted to the position of Vice President R&D in 2003.
In January 2010, he became President of Global Market Development (GMD) of Aptar Pharma’s Prescription Division. In this role, he managed and coordinated worldwide activities which included Scientific and Regulatory Affairs, Business Development, Communication, Engineering, Innovation, Marketing, Projects, and R&D.
Aptar Pharma’s Prescription Division will leverage Jean-Marc Pardonge’s in-depth knowledge of both the pharmaceutical market and the Division’s customers to take full advantage of market opportunities for growth.
